The stock market experienced a pause in its recent rally, with the S&P 500 down about 0.6% and the Nasdaq 100 off by 1%, largely led by declines in big tech stocks. Despite this, bond markets showed little reaction, with the 10-year Treasury yield slightly higher and the Bloomberg Dollar Spot Index up by 0.3%. The mixed tech earnings, particularly from Microsoft, Meta, and Alphabet, shifted market sentiment. Investors are concerned about the massive capital expenditures on AI infrastructure, especially Meta’s decision to borrow $30 billion to fund its AI ambitions. While Alphabet’s investments are viewed more favorably, the market awaits Amazon’s earnings to reassess sentiment. The scale of AI investments is staggering, with companies spending a significant portion of their combined $1.5 trillion annual revenue, raising questions about the return on these investments.
Kamal Bhatia, CEO of Principal Asset Management, discussed the unprecedented level of AI investment by mega-cap tech companies, which traditionally have been capital-light but now must spend heavily to participate in the AI transformation. He emphasized the challenge for public investors in valuing these companies, noting that while real estate investments have tangible valuation metrics, technology investments are rapidly evolving and harder to assess. Bhatia suggested that investors should be selective and consider opportunities beyond just tech companies, including sectors like healthcare and retail, which are also being transformed by AI. He also highlighted the importance of financial literacy in helping investors manage debt and participate effectively in the market’s growth.
Starbucks CEO Brian Niccol shared insights on the company’s turnaround strategy, emphasizing improvements in service through the “Green Apron” initiative, which involved hiring and retraining staff to enhance customer experience. Niccol reported modest growth after six quarters of contraction, with positive momentum continuing into October and strong performance in markets like Canada and China. Starbucks is also investing in store upgrades to create more comfortable and cost-effective locations, aiming to complete over 1,000 store uplifts this fiscal year. Niccol expressed optimism about the company’s future profitability, driven by increased transactions and customer satisfaction, and highlighted the early success of protein-enhanced drinks as a promising new product line.
In healthcare, Eli Lilly outperformed expectations with strong revenue growth from weight loss and diabetes drugs, solidifying its lead over competitor Novo Nordisk in the obesity market. Goldman Sachs’ Asad Haider noted Eli Lilly’s dominance in the GLP-1 market and its robust pipeline of obesity treatments. Meanwhile, Merck reported a slight beat but faced concerns over delayed growth drivers amid an impending patent cliff. Investors reacted positively to Eli Lilly and Bristol-Myers Squibb’s results, while Merck’s stock faced pressure. The healthcare sector’s earnings reflect ongoing competition and innovation in obesity and other therapeutic areas.
The earnings season also featured Amazon and Apple, with Amazon beating revenue and earnings estimates, driven by 13% year-over-year growth and a 20% increase in AWS sales, signaling renewed momentum in its cloud business. Amazon’s shares surged over 10% in after-hours trading. Apple reported a record September quarter with $102.5 billion in revenue and strong iPhone sales, though its Greater China revenue missed estimates, causing some after-hours volatility. Analysts noted Apple’s cautious approach to AI investment but highlighted its strong ecosystem and upcoming product innovations, including a foldable iPhone expected next year. The market’s reaction to these earnings underscores the ongoing investor focus on AI spending, cloud growth, and the evolving competitive landscape in tech.
